Download FREE Report Sample
Download Free sampleCyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
Cyclophosphamide Market contains market size and forecasts of Cyclophosphamide in global, including the following market information:
Global Cyclophosphamide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cyclophosphamide Market Sales, 2017-2022, 2023-2028, (Person)
Global top five Cyclophosphamide companies in 2021 (%)
The global Cyclophosphamide market was valued at 662.1 million in 2021 and is projected to reach US$ 761.1 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
High-Dose Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cyclophosphamide include Baxter, Novartis, Hikma Pharmaceuticals, Amneal Pharmaceuticals LLC, Jiangsu Hengrui Medicine, NorthStar Rx LLC, GLS Pharma and CSC Pharmaceuticals International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cyclophosphamide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cyclophosphamide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Person)
Global Cyclophosphamide Market Segment Percentages, by Type, 2021 (%)
High-Dose
Low-Dose
Global Cyclophosphamide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Person)
Global Cyclophosphamide Market Segment Percentages, by Application, 2021 (%)
Cancer
Autoimmune Diseases
AL Amyloidosis
Others
Global Cyclophosphamide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Person)
Global Cyclophosphamide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cyclophosphamide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cyclophosphamide revenues share in global market, 2021 (%)
Key companies Cyclophosphamide sales in global market, 2017-2022 (Estimated), (Person)
Key companies Cyclophosphamide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Novartis
Hikma Pharmaceuticals
Amneal Pharmaceuticals LLC
Jiangsu Hengrui Medicine
NorthStar Rx LLC
GLS Pharma
CSC Pharmaceuticals International
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
